Jesper Lau

Jesper Lau, vice president of Novo Nordisk A/S, Copenhagen, Denmark. Dr. Jesper Lau studied biology and chemistry at University of Southern Denmark. After receiving his Ph.D. degree in 1990 and a research visit stay at Dr. B. Trost’s laboratory in Standford University (U.S.A.), he joined Novo Nordisk. In 1995 he became responsible for implementing combinatorial chemistry strategy and in 2002 he established a new department to improve therapeutic properties of peptides and proteins. Dr. Lau has a broad experience in both small molecule and protein drug discovery. He was instrumental to the successful development of once weekly glucagon-like peptide-1 and is the first inventor of semaglutide. 活动家作为专业第三方嘉宾邀约平台，依托互联网公开数据为您提供嘉宾信息展示服务。若您发现嘉宾信息需要更新或移除，请发送邮件或联系客服。 我们专注于根据您的具体需求（包括演讲议题、会议日期及活动预算等），为您精准匹配各领域专业嘉宾。 为高效服务，建议您提前准备好详细活动信息，并拨打客服电话：18911802888（工作日9:00-18:00）。 温馨提示：本服务仅限嘉宾邀约相关事宜，其他需求暂不处理，感谢您的理解与配合。